Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
出版年份 2019 全文链接
标题
Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-03-29
DOI
10.3389/fphar.2019.00310
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease
- (2019) Lynn Pulliam et al. JOURNAL OF NEUROVIROLOGY
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease
- (2019) Dilan Athauda et al. JAMA Neurology
- Neural-Derived Extracellular Vesicles in Clinical Trials
- (2019) Dena B. Dubal et al. JAMA Neurology
- Liquid biopsy and minimal residual disease — latest advances and implications for cure
- (2019) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
- (2018) Harald Hampel et al. Alzheimers & Dementia
- High complement levels in astrocyte-derived exosomes of Alzheimer disease
- (2018) Edward J. Goetzl et al. ANNALS OF NEUROLOGY
- Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment
- (2018) Yong Shen et al. BIOLOGICAL PSYCHIATRY
- Untangling Genetic Risk for Alzheimer’s Disease
- (2018) Anna A. Pimenova et al. BIOLOGICAL PSYCHIATRY
- Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease
- (2018) Edward J. Goetzl et al. FASEB JOURNAL
- Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
- (2018) Harald Hampel et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Sex differences in Alzheimer disease — the gateway to precision medicine
- (2018) Maria Teresa Ferretti et al. Nature Reviews Neurology
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision pharmacology for Alzheimer’s disease
- (2018) Harald Hampel et al. PHARMACOLOGICAL RESEARCH
- Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseases
- (2018) Hugo Geerts et al. Expert Review of Clinical Pharmacology
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers
- (2018) Andrea Vergallo et al. Alzheimers & Dementia
- Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease
- (2018) Jong-Chan Park et al. BRAIN
- Going to the negative: genomics for optimized medical prescription
- (2018) Greg Gibson NATURE REVIEWS GENETICS
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- The FDA Oncology Center of Excellence and precision medicine
- (2017) Kirsten B Goldberg et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Altered cargo proteins of human plasma endothelial cell–derived exosomes in atherosclerotic cerebrovascular disease
- (2017) Edward J. Goetzl et al. FASEB JOURNAL
- Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy
- (2017) Xiaolan Deng et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes
- (2017) Maja Mustapic et al. Frontiers in Neuroscience
- Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Network motifs modulate druggability of cellular targets
- (2016) Fan Wu et al. Scientific Reports
- Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
- (2016) Yuhai Zhao et al. Frontiers in Neuroscience
- A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson’s Disease
- (2016) Patrick Roberts et al. Frontiers in Pharmacology
- miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study
- (2016) Sofie Sølvsten Sørensen et al. Translational Neurodegeneration
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study
- (2015) Massimo S. Fiandaca et al. Alzheimers & Dementia
- New Frontiers in Druggability
- (2015) Dima Kozakov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Distinctive Behaviors of Druggable Proteins in Cellular Networks
- (2015) Costas Mitsopoulos et al. PLoS Computational Biology
- Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
- (2015) Hugo Geerts et al. Frontiers in Pharmacology
- Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
- (2014) Nicholas C. Nicolaides et al. Frontiers in Oncology
- Developing novel blood-based biomarkers for Alzheimer's disease
- (2013) Heather M. Snyder et al. Alzheimers & Dementia
- The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication
- (2013) Mathias Rask-Andersen et al. Annual Review of Pharmacology and Toxicology
- Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment
- (2013) K Nho et al. MOLECULAR PSYCHIATRY
- Biomarkers in Alzheimer's disease drug development
- (2011) Jeffrey L. Cummings Alzheimers & Dementia
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started